Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Collegium Pharmaceutical, Inc.
COLL
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five) at other companies
Kadant
KAI
$174.06M
+28.8%
Financial Institutions
FISI
$484K
-29.2%
Clarivate
CLVT
$4.76B
—
OceanFirst Financial
OCFC
$212K
-67.0%
First Commonwealth Financial
FCF
$0
-100%
Rumble, Inc.
RUM
$293.74K
-35.0%
Segments
By product
See full
Jornay Pm
$104.78M
-44.4%
Symproic and other
$6.07M
—
Other financials
Income statement
See full
Revenue
$193.5M
+8.9%
Gross profit
$117.2M
+20.5%
Operating income
$30.9M
+42.5%
Net income
$14.5M
+500%
EPS (diluted)
$0.40
+471%
Balance sheet
See full
Cash & equivalents
$289.6M
+147%
Total debt
$5.2M
-19.5%
Total equity
$312.4M
+33.3%
Total assets
$1.7B
+1.3%
Cash flow
See full
Operating cash flow
$57.1M
+3.1%
CapEx
$270.0K
-66.2%
Free cash flow
$56.8M
+4.1%
Valuation
See full
Market cap
$1.15B
+20.4%
Enterprise value
$869.67M
+2.5%
P/E
15.4×
-6.4×
P/S
1.5×
0.0×
Profitability
See full
Gross margin
60.7%
+3.0pp
Operating margin
23.7%
+2.3pp
Net margin
9.4%
+2.8pp
FCF margin
41.4%
+10.4pp
Returns & leverage
See full
Return on equity
27.4%
+8.2pp
Debt / equity
0×
0.0×
Current ratio
1.7×
+0.6×